Prof Miriam Koopman, a medical oncologist from the Utrecht University Medical Centre in the Netherlands, presented the findings of the CAIRO-4 study. This study, conducted by the Dutch Colorectal Cancer Group, aimed to evaluate the potential advantages of upfront primary tumour resection followed by systemic therapy in patients diagnosed with synchronous metastatic colorectal cancer.
The CAIRO-4 study focused on assessing the potential benefits of a treatment strategy that involved surgically removing the primary tumour as the initial step, followed by systemic therapy. The goal was to investigate whether this approach could improve outcomes in patients with synchronous metastatic colorectal cancer.
With the educational support of:
